Cargando…
The (re)discovery of tumor-intrinsic determinants of immune sensitivity by functional genetic screens
Functional genetic screens by CRISPR-Cas9 allow for the unbiased discovery of proteins causally involved in complex biological processes. In recent years, this approach has been used by multiple laboratories to uncover a range of tumor cell regulators determining immune sensitivity. In this review,...
Autores principales: | Vredevoogd, D.W., Apriamashvili, G., Peeper, D.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216628/ https://www.ncbi.nlm.nih.gov/pubmed/35756970 http://dx.doi.org/10.1016/j.iotech.2021.100043 |
Ejemplares similares
-
Heterogeneity in functional genetic screens: friend or foe?
por: Vredevoogd, David W., et al.
Publicado: (2023) -
RNF31 inhibition sensitizes tumors to bystander killing by innate and adaptive immune cells
por: Zhang, Zhengkui, et al.
Publicado: (2022) -
Ubiquitin ligase STUB1 destabilizes IFNγ-receptor complex to suppress tumor IFNγ signaling
por: Apriamashvili, Georgi, et al.
Publicado: (2022) -
A genome‐wide CRISPR screen identifies FBXO42 involvement in resistance toward MEK inhibition in NRAS‐mutant melanoma
por: Nagler, Adi, et al.
Publicado: (2019) -
Single-cell CRISPR immune screens reveal immunological roles of tumor intrinsic factors
por: Hou, Jiakai, et al.
Publicado: (2022)